Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRFIP1P1 is a processed pseudogene in the human genome with high sequence similarity to the functional gene LRR binding FLII interacting protein 1 (LRRFIP1). As a pseudogene, LRRFIP1P1 does not encode a functional protein product. Pseudogenes can sometimes regulate their parent gene by acting as competing endogenous RNAs (ceRNAs) or miRNA sponges, affecting the stability and translation of the original gene's mRNA, but this specific role has not been documented for LRRFIP1P1. Its designation as a pseudogene means it lacks the canonical molecular functions or disease associations typical of drug targets, and it is not included among therapeutic targets in pharmacology or drug development resources. LRRFIP1P1 should not be regarded as a receptor, enzyme, transporter, or any other kind of canonical drug target. Its utility or importance, if any, relates only to genomics or possible regulatory RNA roles yet to be demonstrated specifically for this pseudogene. There are no known drugs, mechanisms, or diagnostic implications tied specifically to LRRFIP1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRR binding FLII interacting protein 1 pseudogene 1 (LRRFIP1P1).